Episode
Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
- Published
- Jul 2, 2026
- Duration seconds
- 2158
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/androgen-deprivation-therapy-for-prostate-cancer-an-interview-with-dr-rana-r-mckay/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/androgen-deprivation-therapy-for-prostate-cancer-an-interview-with-dr-rana-r-mckay.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Featuring an interview with Dr Rana R McKay, including the following topics: Prostate Cancer Working Group (PCWG4) revised terminology (0:00) Cardiovascular effects associated with GnRH agonists versus antagonists; mechanism of action (2:17) Combination therapy using relugolix; factors affecting persistence and adherence to GnRH agents (12:06) Takeaways from the Phase III EMBARK study (19:36) Use of CAR (chimeric antigen receptor) T-cell therapy and T-cell engagers (27:20) Potential role of circulating tumor DNA minimal residual disease testing; use of olaparib/radium-223 (29:24) CME information and select publications